US Edition
Health Removes Several Units of a Drug for Allergic Conjunctivitis
Summary by redaccionmedica.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
The Spanish Agency for Medicinal Products and Health Products (Aemps) has withdrawn several units of Bentifen, an eye drops used to treat the symptoms of seasonal allergic conjunctivitis thanks to the active substance ketotifeno. The reason, as indicated by the Aemps, is that its sterility cannot be guaranteed because there have been problems of microbiological contamination in the manufacturing plant of this medicine. Although the Agency notes …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
